- Report
- May 2025
- 189 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 196 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 184 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 198 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 187 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 197 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 191 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 191 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 195 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 196 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 186 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 199 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 198 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 190 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 182 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 181 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 192 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 199 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 190 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP
- Report
- May 2025
- 188 Pages
Global
From €3124EUR$3,545USD£2,709GBP
€3471EUR$3,939USD£3,010GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more